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There is a large treatment gap for mental health care in low- and middle-income countries (LMICs), with the majority
of people with mental, neurological, and substance use (MNS) disorders receiving no or inadequate care. Health system
factors are known to play a crucial role in determining the coverage and effectiveness of health service interventions,
but the study of mental health systems in LMICs has been neglected. The ‘Emerging mental health systems in LMICs’
(Emerald) programme aims to improve outcomes of people with MNS disorders in six LMICs (Ethiopia, India, Nepal,
Nigeria, South Africa, and Uganda) by generating evidence and capacity to enhance health system performance in
delivering mental health care. A mixed-methods approach is being applied to generate evidence on: adequate, fair,
and sustainable resourcing for mental health (health system inputs); integrated provision of mental health services
(health system processes); and improved coverage and goal attainment in mental health (health system outputs).
Emerald has a strong focus on capacity-building of researchers, policymakers, and planners, and on increasing service
user and caregiver involvement to support mental health systems strengthening. Emerald also addresses stigma and
discrimination as one of the key barriers for access to and successful delivery of mental health services.
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A health system can be defined as “the sum total of all the
organizations, institutions, and resources whose primary
purpose is to improve health” [1]. A well-functioning
health system should deliver services of adequate quality
to all people, whenever and wherever they need them [1],
and should protect the right to health for everyone, in-
cluding people with mental, neurological, and substance
use (MNS) disorders [2,3], whether through professional
services or non-professional care services such as family
or self-care.
However, health systems often fail to meet the needs
of people with MNS disorders. They are particularly
overstretched in low- and middle-income countries
(LMICs), due to the higher overall burden of disease in* Correspondence: maya.semrau@kcl.ac.uk
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and the lower availability of human and financial re-
sources. Even though three-quarters of the global disease
burden that is due to MNS disorders affects LMICs [4],
and 8.9% of the disease burden in LMICs is due to MNS
disorders (30.1% when excluding mortality) [5], only a
very small proportion of the health budget in LMICs is
allocated to the treatment and prevention of these disor-
ders (an average of 1.9% in lower-middle income coun-
tries, and 0.5% in low-income countries) [6].
The result of this imbalance is a substantial treatment
gap whereby only a small minority of people with MNS
disorders receive any form of treatment, and an even
smaller proportion receive appropriate and evidence-
based care, i.e., care that is continuous, coordinated, and
multi-sectorial. A large multi-country survey showed that,
on average, 76% to 85% of people with severe mental dis-
orders in low-income countries had not received any
treatment in the previous 12 months [7]. This lack ofl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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including disability [7-9] and suicide [10,11].
Recent advances in global mental health
There have been several landmark international achieve-
ments and publications that have significantly improved
the knowledge base to mitigate against the substantial
burden of MNS disorders. These include the World
Health Report in 2001 [12]; the two Lancet series on
global mental health in 2007 and 2011; the Movement
for Global Mental Health [13]; WHO’s Mental Health
Gap Action Programme (mhGAP) for scaling up services
for MNS disorders [14,15]; a review of Grand Challenges
in Global Mental Health [16]; the establishment of Col-
laborative Hubs for International Research in Mental
Health by the National Institute of Mental Health, USA
[17]; the WHO resolution in 2012 and action plan in
2013 [18] to address the global burden of MNS disorders,
whose key objectives strongly reflect a health systems ap-
proach; as well as the on-going PRogramme for Improving
Mental health carE (PRIME) [19,20], which aims to de-
velop, deliver, scale-up, and evaluate evidence-based pack-
ages of care in five African and Asian countries.
However, most of the existing knowledge base and on-
going work is focused on the prevalence of MNS disor-
ders, and evidence of effectiveness and feasibility of local
interventions, with particular emphasis on the adoption
of task-sharing to increase access to integrated services.
What is still lacking is proof and capacity in mental
health system strengthening, i.e., the health system re-
quirements necessary to scale-up integration of mental
health care into other health systems (particularly pri-
mary health care) in LMICs. This includes health system
inputs (for instance, human and financial resource devel-
opment), health-system processes, and system-level in-
formation outputs, as well as knowledge exchange and
dissemination. This is especially important for LMICs,Figure 1 Conceptual scheme linking system inputs, processes, and ouwhich are often undergoing an epidemiological transi-
tion of disease from infectious or communicable diseases
towards a rising burden of chronic illnesses, including
non-communicable conditions such as MNS disorders.
It is imperative that health systems adapt to provide the
collaborative (integrated) model of care shown to best
meet the needs of people with chronic disorders [21].
Often in LMICs the existing health systems are more ori-
entated to acute conditions, which results in fragmented
care, erratic medication supplies, resource problems, or
lack of sustainability of services for long-term disorders. It
is these issues at the health-system level that the Emerald
programme is committed to address.
Aims and objectives of Emerald
Emerald is an international programme of work running
from 2012 to 2017 [22]. The aims are to improve mental
health outcomes in six LMICs by generating evidence
and capacity to enhance health system performance,
thereby improving mental health care in the respective
countries, and helping to reduce the mental health treat-
ment gap. It aims to do so by i) identifying key barriers
within health systems to the effective delivery of mental
health services, and ii) offering solutions for an improved
delivery of mental health services in the future.
Figure 1 shows a conceptual schema of the key aspects
of a mental health system. The system requires inputs
(for example, human and financial resources), which can
be employed to finance and deliver appropriate services.
These actions produce the outputs and outcomes that the
system sets for itself (including good service quality and
financial protection, as well as improved health). System
inputs, processes, outputs, and outcomes are evaluated
and adapted to reflect the changing needs of the popula-
tion and engender improvements in the mental health sys-
tem [23]. In line with this framework and the goals of the
WHO’s Global Action Plan for mental health (2013–2020)tputs in the Emerald programme.
Semrau et al. BMC Medicine  (2015) 13:79 Page 3 of 9[18], the three overarching objectives of Emerald are to ad-
dress: i) adequate, fair, and sustainable resourcing for men-
tal health (health system inputs); ii) integrated provision of
mental health services (health system processes); and iii)
improved coverage and goal attainment in mental health
(health system outputs).
In addition to these three health system objectives, funda-
mental to Emerald is the enhancement of in-country cap-
acities and skills to plan, implement, evaluate, and sustain
system improvements.
The programme is closely linked to, and complements,
the PRIME programme [19,20]. Whilst PRIME focuses
on mental health service development at the commu-
nity, facility, and district level, Emerald concentrates onTable 1 Indicators of development, health resources, and the
Ethiopia India
Administrative Health Units (AHU) in
which Emerald is implemented
Sodo Sehore
(Madhya P
Population of AHU 165,000 1,311,008
Country-level indicators
Economic and financial
World Bank resource category Low Lower-mid
% GDP spent on health 5.9 4.2 ♦
% Health budget spent on mental health Not known 0.06 ♦
Service availability (per 100,000)
Mental health outpatient facilities 0.06 0.33 ♦
Psychiatric beds in general hospitals 0.04 0.82 ♦
Beds in mental hospitals 0.35 1.47 ♦
Human resources (per 100,000)
Psychiatrists 0.04 0.30 ♦
Nurses 0.59 0.17 ♦
Psychologists 0.02 0.05 ♦
Governance
Mental health policy and/or legislation that
is up-to-date (i.e., updated in last 10 years)
and in accordance with international
human rights
Yes (policy)
No (legislation)
No
Workforce capacity and training
Most primary health care doctors had
mental health training in last 5 years
No No
Primary care nurses can independently
diagnose and treat mental disorders
No No
Information systems
Data on number of outpatients with
mental disorders
Not known No
Data on number of persons with
mental disorders treated in
primary health care
Yes No
♦ Data taken from WHO’s Mental Health Atlas (2011) [24].
♦♦ Data taken from WHO’s AIMS (2006) [25].establishing or strengthening the mental health systems
required to implement these services, particularly at the
district, regional, and national levels.Emerald countries and sites
The Emerald programme is working to strengthen mental
health systems in Ethiopia, India, Nepal, Nigeria, South
Africa, and Uganda (Table 1). These countries, to differing
degrees, all face mental health system challenges that are
common across LMICs such as weak governance, low
resource bases, or poor information systems. The six coun-
tries were invited into the programme due to the com-
mitment of local researchers and policymakers, and themental health system in the six Emerald countries
Nepal Nigeria South Africa Uganda
radesh)
Chitwan Oshogbo Kenneth Kuanda
Dist. NW Province
Kamuli
575,058 288,455 632,790 740,700
dle Low Lower-middle Upper-middle Low
5.3 ♦♦ 5.0 8.4 7.3
0.17 ♦♦ 0.40 4.50 0.44
0.08 ♦ 0.03 6.85 0.08
1.0 ♦♦ 0.20 2.70 1.24
0.20 ♦♦ 2.53 19.50 1.48
0.13 ♦♦ 0.12 0.27 0.09
0.27 ♦♦ 0.60 9.72 0.76
0.02 ♦♦ 0.02 0.31 0.02
No Yes Yes No
No No Not known Yes
No Yes No Yes
Yes No No Yes
No No Yes Yes
Box 1 Example case study of the Emerald programme
in Ethiopia
Ethiopia’s Federal Ministry of Health is confronting a mental
health care gap (i.e., the number of people with severe mental
disorder who receive no treatment) of over 90% for people with
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relating to mental health policy or service development).
Due to the diversity of the sites, for instance, with regard to
their geographical, economic, socio-cultural, and urban/
rural contexts, this may increase the programme’s relevance
to a range of other LMIC settings.severe mental illness. In response, the Ministry has launched
ambitious plans to scale-up mental health care integrated into
primary care services in line with the WHO’s Mental Health Gap
Action Programme. A National Mental Health Symposium was
convened in August 2014 to bring together key stakeholders
and galvanise support for the scale-up. In support of these ef-
forts, timely information is being provided by the Ethiopia Emer-
ald programme’s qualitative study with national and district-
level health service planners, which identified key system bar-
riers (e.g., weak systems for monitoring, evaluating, and learning
as scale-up proceeds) and facilitators to scale-up (e.g., high level
political will). A workshop will be held to feed back the findings
to health care planners and generate dialogue about a frame-
work for intervention to address system barriers. Also drawing
on these findings, short courses have been developed by Emer-
ald that will seek to build the capacity of healthcare planners to
strengthen mental health systems in Ethiopia. In synergy with
these efforts, the Emerald-supported adaptation of the One-
Health tool has already been employed for mental health care
planning for the next 5-year cycle by the Ministry of Health.Activities and methods
Emerald entails a large programme of work that is being
implemented through a range of innovative methodolo-
gies (see, for example, the OneHealth tool mentioned
below). In addition, emphasis is placed on service user
and carer involvement, reduction of stigma and discrim-
ination, and dissemination of research findings. To en-
sure the comparability and generalizability of findings,
broadly the same activities and methods are employed
across all six participating countries of the programme,
though some country-specific adaptations may be made
for data collection methods or research instruments to
ensure that these are in line with the different in-country
contexts and to account for the relative strengths and
weaknesses of the health systems of individual countries.
For instance, in investigating how to strengthen govern-
ance processes to facilitate integrated services through key
informant interviews, a generic interview schedule that
covered the key governance issues to be explored was ini-
tially developed; countries then adapted the schedule to
ensure that it was contextually relevant. South Africa’s ad-
aptations included, for example, ensuring that the chal-
lenges associated with implementation of the recent
Mental Health Policy and Action Plan at provincial and
district level were explored. India adopted the schedule to
incorporate questions related to the draft Mental Health
Care Bill and new National Mental Health Policy. In South
Africa also, a range of local service and epidemiological
data were used to adapt the OneHealth tool (see below) to
the South African context. Furthermore, in Nepal, where
the provision of psychotropic drugs in primary health care
is largely absent, a qualitative study was conducted to bet-
ter understand the barriers around procurement and dis-
tribution. In Ethiopia, the non-availability of electricity for
most homes and the lack of diversity of possessions had to
be taken into account when adapting the household eco-
nomic survey (see below for details).
All data from the different sub-studies of the programme
are analysed both on a country-specific level as well as on
a cross-country level. The current status of work varies be-
tween the different sub-studies of the programme in line
with the aims and objectives of the programme; whilst
some are close to completion, others are ongoing or yet to
commence. A case study of some of the work that is being
conducted in one of the Emerald countries, Ethiopia, is
provided in Box 1.Health system inputs
One of Emerald’s key objectives involves the identifica-
tion of health system resources, finance mechanisms,
and information needed to scale-up mental health ser-
vices and move towards universal coverage. This is laid
out across three tasks:
i). Adequacy of resourcing for mental health: For this,
work is in progress to develop and integrate a
module on MNS disorders within the United
Nation’s OneHealth systems planning tool [26].
OneHealth is a tool to strengthen health system
analysis, costing and financing scenarios at the
country level. It does so by bringing together
disease-specific planning and health systems planning,
as well as incorporating modules to estimate the
predicted health impact of scaling up interventions
over time and for assessing fiscal space/financial
sustainability. Through application of this tool, Emerald
provides new estimates of the cost and impact of
scaling up interventions for MNS disorders, as
well as assessing the health system implications of
planned scale-up. This facilitates an integration of
mental health programme-specific strategies into
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from the real world settings of six diverse LMICs,
key requirements for and constraints to local men-
tal health service provision and scale-up are
being built into the tool regarding local mental
health service provision and needs, in a manner
that has not previously been possible. These include,
for example, human resource availability and capacity
at the primary care level, capacity to deliver
psychosocial interventions, and medication availability
at different levels in the system. Three capacity-building
workshops in use of the OneHealth tool have
already been conducted (in Ethiopia, India, and
Nigeria), and currently the estimates of costs and
impacts of scaling up in the six participating Emerald
countries are being finalized within the OneHealth tool.
ii). Fair financing and improved economic outcomes for
mental health: Work is underway for a large survey
in each of the six participating countries with
household members of people with MNS disorders
who attend health care facilities in the study district
(Table 1), to assess the economic impact of people
living with an MNS disorder and the economic
impact of improved care. The household survey is
based on the previously validated WHO survey on
health and ageing (SAGE) developed specifically for
use in LMICs [27], but has been adapted to fit the
aims and objectives of the Emerald programme. The
survey includes questions around household
composition, income, and spending (on health care,
including sources and sectors beyond the
professional such as use of traditional/religious
healers, as well as other services and goods).
iii). Sustainable financing for mental health: This will
involve data analysis as well as in-depth consultations
with policymakers, planners, economists, and
other stakeholders regarding potential financing
mechanisms for mental health care in each country,
building on findings derived from the OneHealth tool
(resource needs) and the household survey (financial
burden and equity).
Health system processes
Another key objective for Emerald is the evaluation of the
context, process, experience, and health system implica-
tions of mental health service implementation. All six par-
ticipating countries are using local adaptations of the
WHO mhGAP Intervention Guide (mhGAP-IG) [14,15]
to facilitate the scaling-up of integrated mental health ser-
vices. The mhGAP-IG includes diagnostic and treatment
guidelines for nine MNS disorders common in LMICs, or
which have a major public health impact or are associated
with human rights abuses. Key strategies to support the
development and implementation of mental health plansin LMICs from the district through to national levels are
identified within Emerald. This is achieved, inter alia,
through:
i). Documentary analyses of key legislation and policy
documents at national, provincial, and/or district
level at the beginning of the programme, to facilitate
the implementation of legislative and policy
imperatives (completed).
ii).Using a governance framework proposed by Siddiqi
et al. [28], qualitative key informant interviews with
relevant groups (such as policymakers, managers,
district service providers, community service officers,
service users, and carers) are being conducted at the
start and end of the programme to better understand
governance processes that enable or inhibit the
development and implementation of mental health
policies, plans, and legislature for integrated mental
health care (including factors outside of the professional
health care system (such as traditional/religious
healers) due to the plurality of services), and to
identify strategies to strengthen these processes.
iii). A mixed-method baseline and endline assessment of
the impact of integrated care on the health system in
the six participating countries, using questionnaires,
observations within health care facilities, and
semi-structured interviews with key informants.
Health system outputs
Emerald’s third key objective focuses on the development,
use, and monitoring of indicators for mental health service
coverage and system performance. This is achieved by: i)
review of existing information systems (completed); ii) a
Delphi study, with an expert panel consisting of 93 mental
health researchers, clinicians, and policymakers almost all
working and residing in LMICs, who have generated and
ranked a set of 52 indicators for routine measurement of
mental health service coverage and system performance
(ongoing); iii) in-depth interviews and focus group discus-
sions with selected health information personnel and
health care providers, to assess barriers related to the
introduction and the use of selected indicators (ongoing);
and iv) monitoring and evaluation of the performance and
utility of the selected indicators (ongoing).
Capacity-building in mental health systems research
In addition to the above three key objectives, Emerald has
a strong focus to build up the capacity of i) local re-
searchers, ii) policymakers and planners to implement sys-
tem improvements for mental health care services, and iii)
service users and caregivers in each participating country.
This is realised through tailored capacity-building inter-
ventions for each of the three stakeholder groups (re-
searchers, policymakers and planners, and service users
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each of the Emerald countries. Approaches include ‘Train-
ing of Trainers’ courses; funding for PhD (five so far; four
are still planned) and Masters students (one so far; another
is planned); supervision and monitoring of PhD students;
mentoring mid-level researchers; workshops and policy di-
alogues; advocacy and empowerment workshops for ser-
vice users and caregivers; and capacity-building amongst
health care providers to work towards greater service user
involvement.
In addition, three Masters-level teaching modules with
28 sub-modules (Table 2) have been developed to build
capacity in mental health systems research within Emerald
countries and beyond, through integration of the modules
into ongoing Masters courses within countries. Each of the
28 sub-modules encompasses at least one full day of face-
to-face teaching, which were identified and agreed within
the Emerald consortium based on the group’s expertise.
The sub-modules were developed through a collabora-
tive effort by all members of the Emerald team in the
first half of 2014, both by adapting materials that had
been previously developed by them or their colleagues,
and by newly developing materials. A peer-review sys-
tem is being employed to improve training materials,
which will be freely and publicly available to use by the
end of the programme.
Service user involvement and reduction of stigma and
discrimination
Partnerships with service users are essential for the devel-
opment of evidence-based care in government guidance
across the globe [29-31]. They may protect those who
receive involuntary treatment abuses, or those who areTable 2 Masters-level modules in mental health system stren
Module 1: Mental health system components Module 2: Men
systems researc
1.1 Introduction to mental and
neurological disorders
2.1 Mental healt
1.2 Health systems concepts
and approaches
2.2 Methods to e
health interv
1.3 Mental health policy 2.3 Economic ev
1.4 Leadership and governance 2.4 Qualitative re
1.5 Service organization 2.5 Collaborative
1.6 Promotion and prevention 2.6 Service user
1.7 Health systems financing 2.7 Research eth
1.8 Human resources 2.8 Implementat
1.9 Information systems and
monitoring and evaluation
2.9 Knowledge t
1.10 Interventions and technologies, delivery
systems, and essential treatments
2.10 Survival skil
1.11 Human rights/equitymarginalized due to their low socio-economic status or
social stigma attached to MNS disorders, through their
greater involvement in the implementation of mental
health system processes. Close collaborations between ser-
vice users/caregivers and healthcare professionals have
been pioneered in mental health and HIV/AIDS world-
wide, and the evidence of its usefulness is slowly emerging
through a number of recent publications [32]. Service
users and their families and caregivers are thus involved in
all components of the Emerald programme, for example,
through consultations, including qualitative work, to bet-
ter understand contextual factors, capacity-building, and
advocacy activities, and to pilot collaboration to embrace
involvement of all stakeholders.
Since the quantity and level of involvement of service
user organizations varies widely between Emerald coun-
tries (for example, in Uganda, 16,900 service users are
members of service user organizations, whereas in Ethiopia
there are no such organizations), country-specific strategies
are being employed. As part of this, stigma and discrimin-
ation are addressed as one of the key barriers for access to
and successful delivery of mental health services in LMICs
[33-35]. This involves a two-way process, in which in-
creased service user and caregiver involvement is estab-
lished within the programme, and lessons are garnered on
how best to reduce stigma through interviews with service
users and caregivers.
Dissemination
The Emerald programme is working to disseminate its re-
search findings widely to engage with different stakeholder
groups (such as Ministries of Health and Finance in study
countries, policymakers and planners, national andgthening developed within Emerald
tal health
h methods
Module 3: Mental health system
contexts – Areas of special attention
h epidemiology 3.1 Stigma and discrimination
valuate mental
entions
3.2 Child and adolescent
mental health
aluation 3.3 Older adults
search methods 3.4 Suicidal behaviour
care in mental health 3.5 Systems research in
humanitarian settings
and action research 3.6 Women/maternal/gender issues
ics 3.7 Culture and mental health
ion science
ranslation
ls for researchers
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organizations working in mental health, mental health re-
searchers, service users and providers, and caregivers).
This includes the establishment of mental health research
networks within the programme and beyond. Channels
that are employed for this are joint publications in scien-
tific journals, policy briefing papers, conference presenta-
tions and posters, a project website, project flyer, social
media sites, and press conferences.
Challenges
For Emerald, there are several challenges that are specific-
ally addressed through each of the programme’s objectives
as outlined above. These include inadequate resources for
mental health, limited finances, poorly trained staff, a lack
of understanding about service delivery processes and
quality improvement, poor outcome assessment through
health management information systems (HMIS) (for
example, in India, due to a lack of a robust monitoring
framework and the non-integration of mental health indi-
cators with HMIS), difficulties in exchange of knowledge,
and in some countries the low level of empowerment and
the marginalisation of service users and caregivers (in
Ethiopia, for instance).
One of the main barriers is the translation of the pro-
gramme’s findings into practice, particularly to actively
involve decision-makers in the six participating countries
to bring about changes in mental health policy and sys-
tems strengthening for integrated mental health service
provision. For example, in Nepal, the high turn-over of
staff at senior policy levels creates barriers for mental
health system strengthening in terms of having a solid
group of policymakers to advocate and work with. In
India, poor community participation and ownership of
the mental health programme form similar barriers. To
address this, but also to improve the applicability of the
programme within each of the participating countries,
links and partnerships with policymakers, planners, and
other stakeholder groups have been established early on
in the programme. Indeed, an important strength of Em-
erald is the direct involvement of key policymakers from
the Ministries of Health in the six countries as partners
who have been actively engaged from the very inception
of the programme and who contribute to the implemen-
tation of Emerald throughout its tenure.
Building sustainability
The Emerald programme seeks to strengthen mental health
systems in six LMICs by working on health system inputs,
system processes, and performance outputs that are related
to mental health service delivery, thereby addressing a key
implementation science gap. Based on the experience of
the participating countries, the programme aims to produce
a research-informed ‘roadmap’ for decision-makers inLMICs on how best to scale-up mental health services
within the constraints of the broader health system, includ-
ing the identification of the human and budgetary resource
needs to meet locally-determined targets, health finan-
cing policy options, governance requirements, and cover-
age/performance indicators. Furthermore, Emerald aims
to map out and articulate the pathways used in the six
local health systems to integrate mental health care within
existing services. Through documentation of the impact
of this integration, the programme offers health service
providers, both in the six countries and beyond, workable
and tested strategies for sustainable integration. Another
major impact of this programme is the identification,
training, and support for the career progression of mental
health professionals and researchers in LMICs with the
information and skills needed to bring a health systems
perspective to mental health planning, provision, and
evaluation – one that complements existing knowledge,
capacities, and learning opportunities. Indeed, the short-
age of technical know-how has been identified as a major
barrier to the scale-up of mental health services in LMICs,
and Emerald aims to address this. With this comprehen-
sive approach, we plan to improve the evidence base on
how to enhance health system performance and build
capacity to support scaling-up of integrated mental health
care in practice in LMICs.
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